1,349
Total Claims
$270K
Drug Cost
131
Beneficiaries
$2,061
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
+46%
Cost per patient vs peers
$2,061 vs $1,411 avg
+95%
Brand preference vs peers
20.7% vs 10.6% avg
Brand vs Generic
79% generic
Brand: 273 claims · $238K
Generic: 1,046 claims · $27K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 33 | $41K |
| Empagliflozin | 26 | $36K |
| Semaglutide | 24 | $32K |
| Dulaglutide | 13 | $23K |
| Rivaroxaban | 14 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 21 | $15K |
| Varenicline Tartrate | 11 | $3,984 |
| Potassium Chloride | 33 | $3,016 |
| Atorvastatin Calcium | 130 | $1,916 |
| Lidocaine | 16 | $1,881 |
| Albuterol Sulfate | 37 | $1,095 |
| Diclofenac Sodium | 31 | $895 |
| Levothyroxine Sodium | 44 | $888 |
| Pantoprazole Sodium | 39 | $735 |
| Amlodipine Besylate | 92 | $712 |
Prescribing Profile
Patient Profile
72
Avg Age
65%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About